sis, in all patients. We determined patient age and sex, symptoms at presentation, the presence of associated medical conditions, the arteriographic stage of the illness at presentation, and the clinical and neuroimaging-based outcomes of patients after surgery and during late followup examination. We obtained information regarding the functional status by performing late follow-up examinations as well as by reviewing reports from referring physicians, patients, and their families.
We treated 149 patients during the study period. Six of these patients were excluded from further review because atypical preoperative arteriographic findings were documented in four and initial revascularization surgery was performed in two at outside institutions. Of the 143 patients remaining, 89 were female and 54 were male (female/male ratio 1.6:1). The mean age at onset of symptoms was 6.5 years (range 0.3-21 years); the mean age at surgery was 7.1 years (range 0.5-21 years).
Functional status was graded using a mRS for disability scoring ( Table 1) ; for patients under 6 years of age, we estimated a score based on degree of neurological deficit and age-appropriate functional levels.
Results

Mode of Presentation
Most patients presented with a combination of symptoms ( Table 2 ) and many with associated medical conditions or syndromes (Table 3 ). Some conditions overlapped, as might be expected. For example, six children with hypothalamic-optic system gliomas also suffered neurofibromatosis Type 1, and in three children who had undergone surgery for congenital cardiac defects, Down syn-drome was also present. There were eight patients with familial disease from four families (two siblings with the same mother and different fathers, and mother-son, sister-sister, and brother-sister combinations). There were two pairs of identical twins, but MR imaging/angiography results in the sibling of each twin with moyamoya syndrome were normal and the patients were asymptomatic.
Surgical Treatment
Each patient in this series underwent as an initial operation (pial synangiosis) to promote the development of increased blood flow to the involved hemisphere. 1 In this procedure, we transpose and affix the intact STA to the brain surface by using No. 10-0 sutures after the dura mater and arachnoid have been opened widely, maintaining continuity of blood flow in the STA from scalp over the brain surface and back to scalp. The operative technique remained essentially unchanged throughout the 17year study period, except for minor modifications, specifically in the extent of dural and arachnoid opening. We documented the development of new vasculature supplying the brain from the repositioned STA and from meningeal arteries at the craniotomy site by using routine arteriography 1-year postoperatively ( Fig. 2 ).
We performed 271 craniotomies for pial synangiosis in 143 patients, in 96 of whom both hemispheres were treated in the same anesthetic session. In 164 of these craniotomies, we placed a single additional frontal or parietal burr hole, opening dura, arachnoid, and pia to provide a possible additional route of collateral supply to the under-J. Neurosurg: Pediatrics / Volume 100 / February, 2004 Surgical treatment of moyamoya syndrome 143 FIG. 1. Left ICA arteriogram (lateral view), obtained in an 8year-old girl with moyamoya disease. The single arrow points to the stenosis and occlusion of the supraclinoid ICA. Arrowheads indicate the apex of the cloud of moyamoya vessels, which pass through the deep white matter and superficial basal ganglia of the hemisphere to reconstitute the distal cerebral vessels. The ophthalmic artery, seen below the arrow and running anterior (to the left), is supplying a few vessels in the frontal lobe through transdural-cribriform plate collateral structures. lying brain. We used a previously described anesthetic protocol designed to enhance cerebral perfusion; this involves the liberal administration of intravenous fluids and maintenance of normocarbia and normotension. 20 Since late 1994, detection and treatment of cerebral ischemia has been performed in most patients by continuous intraoperative EEG monitoring involving the 10 to 20 international electrode placement system modified to accommodate the surgical incision(s). All patients receive aspirin beginning 24 hours postoperatively, usually at doses of 81 mg/day.
Intraoperative EEG
We recorded EEG data during 98 procedures in 52 patients. Transient EEG slowing suggestive of cerebral ischemia was demonstrated during 60 procedures (66%) and was not associated with anesthetic depth or end-tidal carbon dioxide levels. The slowing generally occurred in both hemispheres simultaneously when the STA was sutured to the brain surface and/or when the bone flap was replaced, suggesting abnormal cerebral reactivity. When we replaced the thrombin-soaked Gelfoam-used to cover the open dura and exposed brain prior to securing the bone flap-with saline-soaked Gelfoam, the incidence of EEG slowing at this intraoperative stage markedly diminished, suggesting that thrombin may induce vasospasm or perhaps enhance the abnormal cerebral reactivity in many of these patients. This observation merits additional laboratory and clinical study, because topical thrombin-soaked Gelfoam and patties are commonly applied in many neurovascular procedures.
Surgical Complications
Eleven strokes (7.7% per patient; 4% per surgically treated hemisphere) and three severe TIAs occurred within the first 30 days after surgery. Neurological instability, defined as the occurrence of a major stroke within 1 month of surgery or multiple strokes within 3 months prior to surgery, was thought to be the major predisposing risk factor in four of these patients. Eleven other patients in whom preoperative status was also deemed unstable, however, did not suffer neurological morbidity during the postoperative period, and therefore this clinical presentation did not automatically convey an increased risk of perioperative stroke. In additional patients, postoperative strokes occurred after episodes of prolonged crying (one patient), after prolonged hypotension following aggressive pharmacological control of postoperative hypertension (two patients, one of whom was also neurologically unstable, as defined previously), and when antiplatelet medication was not begun on the 1st day postoperatively (one patient). The latter patient is the only one in the entire series who did not receive aspirin therapy on postoperative Day 1. Three patients suffered strokes within 30 days of surgery for no obvious reason, despite careful attention to hydration, blood pressure control, and antiplatelet (aspirin) administration. In an additional patient an acute subdural hematoma developed after a fall 20 days postoperatively, and chronic subdural hematomas developed in three patients (45, 53, and 72 days postoperatively, respectively). Two of the chronic subdural hematomas required evacuation via a burr hole, but there was no permanent hematoma-related morbidity in any of these cases.
Long-Term Follow-Up Data
We followed the patients in this series for between 3 months and 17 years after surgery (mean follow-up period 5.1 years, median 4.7 years). Only one patient has been lost to follow up. In 126 patients followed for more than 1 year, there were the following seven late-onset neurological complications: four strokes, one severe reversible ischemic neurological deficit, and two severe persisting TIAs. In these seven patients, symptoms were in the anterior circulation in four, posterior circulation in two, and of unclear distribution in one. Subsequent angiography in the two patients with posterior circulation symptoms demonstrated development of progressive narrowing of the posterior cerebral arteries. We made multiple occipital burr holes in one of these patients because the first follow-up arteriogram revealed impressive collateral structures to the brain through the frontal burr holes made at the time of the initial synangioses. In the other patient, we performed bilateral occipital artery-occipital lobe synangioses. Status in both patients has been stable since reoperation at 2.5 and 3 years, respectively. The three patients with late-onset frontal lobe strokes or ischemia underwent either repeated synangiosis (one patient) or wide frontal craniotomy with onlay of a vascularized periosteal flap ("periosteal synangiosis"). One patient in whom a periosteal synangiosis was performed underwent angiography 1 year after the procedure, but unfortunately no significant new collateral circulation had been created by the procedure.
In two patients subsequent reoperation was undertaken by another neurosurgeon. One patient suffered debilitating headaches and intermittent episodes of visual loss and extremity weakness 7 years after initial synangiosis. Results of CBF studies were interpreted as indicating reduced hemodynamic reserve in both hemispheres despite flow demonstrated through the synangioses. The patient underwent a right STA-MCA anastomosis and a left omental transposition. At follow-up examination 3 years later, the patient still suffered headaches but was otherwise well. Another patient in whom postoperative arteriography demonstrated an excellent result sustained intermittent leg weakness and aphasia aggravated by hyperventilation. This patient underwent bilateral STA-MCA bypass surgery for presumed anterior cerebral artery and anterior cerebral artery-MCA watershed territory ischemia 2 years after initial synangiosis. At 6-month follow-up after the last reoperation, TIAs and hyperventilation have persisted but are less intense and less frequent. The TIAs similar to those at presentation persisted only in one other patient, and six others still experience TIAs of lesser intensity and severity than at presentation.
Headache of varying intensity also has been a common problem in patients postoperatively. The headaches frequently are accompanied by clinical phenomena resembling typical migraine syndromes and have usually responded to antimigraine medication regimens. Finally, because stroke is the most clearly defined symptom in patients with moyamoya disease, both clinically and radiographically, we evaluated the long-term (Ͼ 5-year) surgery-related outcome in the 46 patients in whom stroke alone was the primary symptom at presentation. Only two strokes developed in this group during the long-term follow-up period, a result that indicates the effectiveness of pial synangiosis for reducing stroke in this population, and one made more dramatic by its contrast with the greater number of strokes suffered by each patient before surgery ( Fig. 3 ).
Long-term functional results were clearly related to functional status at the time of surgery (Tables 4 and 5) . Young age at onset of symptoms did not always herald a poor late outcome. For example, of the 19 patients treated at 2 years of age or younger, 10 have exhibited no deficits on late follow-up examination and another four have only sustained mild deficits while remaining totally independent. These results are particularly gratifying because all but one of these very young patients presented after a significant stroke. There were two deaths in this series. A 21-year-old woman in whom moyamoya syndrome was found after radiotherapy for a craniopharyngioma died of a radiationinduced invasive meningioma 5 years after synangiosis. A 12-year-old boy in whom moyamoya syndrome was demonstrated following cranial irradiation and intrathecal chemotherapy for acute lymphoblastic leukemia died 6 years after synangiosis of recurrent hemorrhage secondary to a deep basal ganglia/third ventricular aneurysm on a moyamoya collateral vessel. This case must be considered a surgery-related failure, because his initial 1-year followup angiogram demonstrated only modest new operationinduced collateral vessels. The moyamoya vessels continued to supply considerable blood flow to the brain distal to the severe stenoses in the circle of Willis, perhaps leading to the formation and sequential bleeding from the aneurysm on the deep collateral vessel. There were no deaths due to ischemic stroke in this series.
Arteriographic Findings. Cerebral arteriography and MR imaging/angiography were performed 1 year postoperatively to assess the efficacy of the synangiosis and to guide subsequent management. Although we request 1-year follow-up arteriograms in all of our patients, the studies were refused by some families or could not be obtained in others because of geographical or other considerations. We reviewed either the arteriograms themselves or our previous reports of these studies in the 102 patients in whom these studies were performed. We graded the newly developed collateral vessels according to the method of Matsushima, et al., 14 (Grade A representing synangiosis-induced filling of Ͼ two thirds of the MCA circulation, Grade B between one third and two thirds, and Grade C Ͻ one third). Sixty-five percent of the 195 hemispheres studied were classified as Grade A collateral circulation, 25% as Grade B, and 10% as Grade C. Of the 102 arteriograms, 82 (80%) had at least one hemisphere demonstrating Grade A circulation. Visible collateral vessels to the brain at the additional burr hole sites could be identified in approximately 69 (57%) of the 120 burr holes that could be assessed, but in only 34 (28%) could these vessels be termed significant (that is, filling more than a small focal area at the burr hole site).
Discussion
In the present study we describe moyamoya disease in a consecutive series of patients 21 years of age or younger treated during a 17-year period by a single neurosurgeon. Despite the varied clinical associations observed in this series, the modes of presentation, age at onset of symptoms, and age at surgery were similar to those reported in the Japanese literature. [5] [6] [7] [8] 26 We believe that our series, the largest reported in the Western hemisphere, is representative of the wide spectrum of pediatric cases involving moyamoya disease.
Progression Rate and Long-Term Outcome
In the Japanese literature numerous authors have docu-mented the unfavorable natural history of untreated moyamoya disease, with its gradual neurological and cognitive deterioration 2, 6, 10, 11, 22 as well as mortality rates of up to 4.3% in certain pediatric series. 17 We noted a variable and unpredictable rate of clinical progression of moyamoya disease in our patients and believe that a long follow-up period is necessary to determine the effectiveness of any treatment. The long follow-up period and complete follow-up data in this series allow us to conclude that effective revascularization surgery plays a significant role in halting neurological deterioration in a majority of patients. The exceptions to this conclusion are the few patients in whom synangiosis did not effectively perfuse anterior or posterior cerebral artery circulations and in whom required additional revascularization surgeries were directed at these persistently ischemic areas.
Controversy exists regarding the appropriate initial surgical therapy for moyamoya disease in young patients; 3, 4, 16 however, the present study provides evidence that pial synangiosis, a surgical procedure combining dural and arachnoid opening with the attachment of the donor STA directly to the pial surface by using interrupted No. 10-0 sutures, prevents future associated neurological events in the majority of pediatric patients. The effectiveness of this type of "indirect" surgery likely is enhanced by the increased levels of growth factors in the CSF of children with moyamoya disease; 13, 24, 27 these growth factors may be responsible for the development of new collateral vessels via the skull and dura to the brain through any corridor provided by the neurosurgeon, including burr holes. The additional arteriography-detected collateral structures seen on 1-year postoperative arteriograms obtained through the burr holes placed at the time of synangiosis were extremely variable, however; in most cases, the newly formed vessels were inconsequential, indicating to us the importance of using some type of donor vessel as part of the surgical procedure. Since 2002, we have abandoned the routine placement of additional burr holes at the time of synangiosis and believe that the neurosurgeon should not rely on burr holes alone as a revascularization technique in most patients with moyamoya disease.
The synangiosis-induced collateral vessels themselves appear long lived, and on an arteriogram obtained in one patient 9 years after the initial operation persistent and even some increase in the florid collateral structures were present compared with the initial postoperative study (Fig.  4) . Although concomitant stenosis of the renal arteries was diagnosed in four patients during initial angiography, in all cases the arterial stenosis was otherwise restricted to cerebral vessels around the circle of Willis and did not involve vessels on the brain surface or in the scalp and meninges. Throughout the accrual of this series, selective cerebral arteriography to assess ICA and ECA blood flow was the most useful diagnostic modality by which to assess the cerebral circulation preoperatively and to determine the extent of postoperative CBF through the synangiosis. Magnetic resonance angiography was undertaken as a baseline measure at the time of follow-up arteriography in all patients, but this modality often ineffectively demonstrated the extent of perfusion to the surgically treated hemisphere through the operative site. Because of the constraints implicit in a pediatric population, we were unable to study systematically CBF changes pre-and postoperatively by using positron emission tomography, single-photon emission computerized tomography, or Xebased computerized tomography scanning.
We believe that antiplatelet medication, in particular aspirin, also plays an important role in the postoperative treatment of patients with moyamoya disease. In a condition involving multiple intracranial stenoses such as moyamoya disease, symptoms probably result not only from progressive distal ischemia but also from embolization due to thrombi forming at areas of stenosis. Anticoagulation therapy with agents such as warfarin sodium is dangerous in this pediatric population, not only because of the difficulty of preventing head trauma secondary to unanticipated sources but also because of the potential of life-threatening spontaneous intracranial hemorrhage that can occur in some children with moyamoya syndrome. We prescribe life-long aspirin therapy (usually in doses of 81 mg/day) in all of our patients postoperatively. There are no published studies indicating that aspirin therapy alone will prevent stroke in this patient population, however, and several of our patients were receiving aspirin therapy prior to surgery, with symptoms of ischemia developing nonetheless.
Significance of Intraoperative EEG Findings
During surgery, we commonly observed EEG changes suggestive of transient cerebral ischemia not precipitated by hyperventilation or hypotension, and these occurred during direct surgical stimulation of the brain surface by pial sutures or during bone flap replacement. We postulate that this EEG slowing is due to defective cerebral reactivity; it is not known, however, whether these EEG changes are unique to pial synangiosis or to patients with moy-amoya syndrome in general, or if the finding has longterm clinical significance. One patient in whom surgery was performed in 2002 after the accrual of this clinical series suffered new bilateral hemisphere strokes evident immediately at the completion of her bilateral synangiosis, despite a totally stable intraoperative EEG, indicating that this monitoring technique will not always prevent an adverse operative outcome. We believe that the study of intraoperative EEG warrants further investigation in this patient population.
Clinical Associations
One of the more interesting aspects of moyamoya syndrome has been its association with other pathological processes ( Table 3) , some of which (Down syndrome, congenital cardiac anomalies, congenital giant cervicofacial hemangiomas, and Alagille and Williams syndromes) are characterized by the aberrant development of vascular structures throughout the body. Other patients had undergone medical interventions that may potentially cause cerebral vessel injury, including skull base tumor extirpation, cranial radiotherapy, or intrathecal chemotherapy. Three patients suffered hemoglobinopathies, in which thrombosis in cerebral vasa vasorum has been postulated to damage blood vessel walls. 25 We have noted elevated concentrations of soluble endothelial adhesion molecules in the CSF in a cohort of our patients, 19 suggesting that a chronic inflammatory process might play a role in the development of moyamoya syndrome; however, no evidence of inflammation has ever been identified in the CSF of these patients, and steroid agents have never been shown to ameliorate symptoms or reverse arteriographically documented findings. The few postmortem studies in patients with moyamoya disease have demonstrated only a nonspecific thickening of the intima and endothelial hyperplasia, without evidence of inflammation, 12 and the elevated levels of soluble adhesion molecules in the CSF obtained in patients with moyamoya disease may be the result, rather than cause, of chronic ischemia.
A hereditary or familial syndrome was observed in eight of four patients (5.6%), with either mother-child (two families) or sibling-sibling involvement. In Japan the familial incidence is reported to be as high as 7 to 12%, 9, 18 but in two pairs of identical twins in this series, the second twin was unaffected, indicating that an additional environmental factor must be necessary in certain patients to initiate the arteriopathic process. One adult patient treated by the senior author, not in this series, is also an identical twin whose sibling is unaffected. We found a definite female preponderance similar to that previously demonstrated in the Japanese literature, 21 suggesting that a sex-specific factor as yet unidentified must also play a role in certain forms of the disease.
Six patients exhibited choreiform movements on their initial evaluation. In many patients with moyamoya disease, MR imaging demonstrates accentuated flow voids through the basal ganglia secondary to the dilated moyamoya collateral vessels, and it is possible that in patients with chorea, these vessels have either compressed the basal ganglia or created local ischemia, leading to this symptom complex. After surgery, the abnormal movements have virtually disappeared in each patient by late follow-up examination. Headache resembling the classic migraine has been a frequent symptom both at presentation and follow up and has occasionally been difficult to treat, requiring trials of multiple pharmacological agents for control. We have attributed the development of migraines after synangiosis to enlargement of meningeal vessels newly collateralizing the brain, but the application of this finding to the understanding of classic migraine remains unclear.
Conclusions
In this study our evidence indicates that following a specific revascularization surgery-pial synangiosis-the majority of pediatric patients with moyamoya syndrome cease to experience symptoms of cerebral ischemia and stroke. The surgery halts what is normally a relentless clinical deterioration in the untreated patient. Such surgery is not without risk, especially in the neurologically unstable patient, but nearly 75% of children in our series followed for more than 1 year are leading independent and normal lives.
